Matthew Brams
Oprichter bij CINGULATE INC.
Vermogen: 22 791 $ op 31-05-2024
Actieve functies van Matthew Brams
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CINGULATE INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2013 | - |
| Oprichter | 01-01-2013 | - | |
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Directeur/Bestuurslid | - | - |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2014 | - | |
| Oprichter | - | - | |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Hoofd Techniek/Wetenschap/O&O | 01-01-2013 | - |
| Oprichter | 01-01-2013 | - | |
| Baylor College of Medicine | Corporate Officer/Principal | - | - |
Loopbaan van Matthew Brams
Eerdere bekende functies van Matthew Brams
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Bayou City Research, Inc. | Hoofd Techniek/Wetenschap/O&O | 01-04-1999 | 01-01-2021 |
Opleiding van Matthew Brams
| The University of Texas at Austin | Undergraduate Degree |
| University of Texas Health Science Center at Houston | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
Operationeel
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 3 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
| Bayou City Research, Inc. |
- Beurs
- Insiders
- Matthew Brams
- Ervaring
